Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [U2OS ATAC-Seq]

ABSTRACT: Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [U2OS ATAC-Seq]

PROVIDER: PRJNA542335 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9041010_1.fastq.gz	Fastqsanger.gz
	SRR9041010_2.fastq.gz	Fastqsanger.gz
	SRR9041011_1.fastq.gz	Fastqsanger.gz
	SRR9041011_2.fastq.gz	Fastqsanger.gz
	SRR9041004_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [U2OS ATAC-Seq]

Project description:The Tousled like kinases 1 and 2 (TLK1/2) control histone deposition through the ASF1 histone chaperones and are regulated by the DNA damage response. Depletion of TLK activity caused replication stress, increased chromosomal instability and cell arrest or death. Here, we show that stalled forks in TLK depleted cells are processed by BLM, SAMHD1 and the MRE11 nuclease to generate ssDNA and activate checkpoint signaling. TLK depletion also impaired heterochromatin maintenance, inducing features of alternative lengthening of telomeres and increasing spurious expression of other repetitive elements, associated with impaired deposition of the histone variant H3.3. TLK depletion culminated in a BLM-dependent, STING-mediated innate immune response. In many human cancers, TLK1/2 expression correlated with signatures of chromosomal instability and anti-correlated with STING and innate and adaptive immune response signatures. Together, our results show that TLK activity protects replication forks from active processing, contributes to chromatin silencing and suppresses innate immune responses, suggesting that TLK amplification may protect chromosomally unstable cancers from immune detection.

2020-07-21 | GSE131020 | GEO

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling

Project description:Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling

| PRJNA542332 | ENA

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [ChIP-Seq]

2020-07-21 | GSE131021 | GEO

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [RNA-Seq]

2020-07-21 | GSE131019 | GEO

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [HeLa ATAC-Seq]

2020-07-21 | GSE131022 | GEO

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [ChIP-Seq]

Project description:Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [ChIP-Seq]

| PRJNA542334 | ENA

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [RNA-Seq]

Project description:Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [RNA-Seq]

| PRJNA542336 | ENA

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [HeLa ATAC-Seq]

Project description:Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling [HeLa ATAC-Seq]

| PRJNA542333 | ENA

Tousled-like kinase activity is required for transcriptional silencing and suppression of innate immune signaling

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-07-21 | GSE131023 | GEO

U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2

Project description:U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 Keywords: other

2005-04-06 | GSE2292 | GEO